D van der Heijde Selected Research

D van der Heijde Research Topics

Disease

33	Ankylosing Spondylitis 01/2019 - 07/2000
25	Rheumatoid Arthritis 01/2017 - 04/2001
17	Necrosis 03/2016 - 09/2002
12	Back Pain (Backache) 01/2015 - 05/2004
11	Psoriatic Arthritis 01/2017 - 08/2006
11	Arthritis (Polyarthritis) 09/2014 - 09/2000
10	Axial Spondyloarthritis 06/2017 - 06/2009
10	Inflammation (Inflammations) 04/2016 - 09/2002
9	Pain (Aches) 12/2018 - 01/2001
7	Rheumatic Diseases (Rheumatism) 03/2016 - 03/2005
7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015 - 05/2004
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2014 - 05/2004
5	Sacroiliitis 09/2014 - 05/2004
3	Disease Progression 04/2016 - 06/2004
3	Infections 01/2014 - 09/2000
3	Spondylarthropathies 11/2005 - 09/2000
2	Synovitis 04/2016 - 10/2009
2	Osteoarthritis 04/2016 - 11/2000
2	Uveitis 01/2016 - 01/2011
2	Anterior Uveitis 09/2014 - 05/2004
2	Reactive Arthritis (Reiter Disease) 09/2000 - 07/2000
1	Spondylitis 09/2014
1	Opportunistic Infections (Opportunistic Infection) 01/2014
1	Neoplasms (Cancer) 01/2014
1	Non-Radiographic Axial Spondyloarthritis 01/2014
1	Tenosynovitis 10/2009
1	Rheumatoid Nodule 11/2008
1	Ankylosis 09/2008
1	Spinal Diseases (Disease, Spinal) 04/2008
1	Ulcerative Colitis 05/2007
1	Crohn Disease (Crohn's Disease) 05/2007
1	Joint Diseases (Joint Disease) 05/2006
1	Fibromyalgia (Fibrositis) 03/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2005
1	Fatigue 01/2005

Drug/Important Bio-Agent (IBA)

13	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 04/2004
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 09/2002
11	Etanercept (Enbrel)FDA Link 01/2014 - 09/2002
10	Certolizumab Pegol FDA Link 01/2017 - 06/2009
10	Infliximab (Remicade)FDA Link 02/2009 - 09/2002
8	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2015 - 05/2004
7	C-Reactive ProteinIBA 01/2017 - 11/2004
7	Antirheumatic Agents (DMARD)IBA 01/2017 - 01/2009
6	Tumor Necrosis Factor InhibitorsIBA 03/2016 - 04/2008
6	AntibodiesIBA 01/2016 - 09/2000
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 08/2001
5	HLA-B27 Antigen (HLA B27 Antigen)IBA 06/2017 - 07/2000
4	ametantrone (HAQ)IBA 01/2015 - 01/2005
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2014 - 09/2003
4	Biomarkers (Surrogate Marker)IBA 01/2010 - 04/2008
3	Gadolinium DTPA (Magnevist)FDA Link 03/2014 - 11/2002
3	GadoliniumIBA 03/2014 - 09/2002
3	cyclic citrullinated peptideIBA 01/2010 - 02/2008
3	SteroidsIBA 07/2009 - 09/2003
3	amsonic acid (DAS)IBA 02/2008 - 11/2005
2	AntigensIBA 01/2011 - 03/2008
2	Anti-Citrullinated Protein AntibodiesIBA 02/2010 - 01/2010
2	Rheumatoid FactorIBA 01/2010 - 11/2008
2	Immunoglobulin A (IgA)IBA 01/2010 - 11/2008
2	Immunoglobulin M (IgM)IBA 01/2010 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 02/2009
2	Adalimumab (Humira)FDA Link 06/2009 - 09/2008
2	EpitopesIBA 02/2009 - 11/2008
2	Immunoglobulin G (IgG)IBA 02/2009 - 03/2008
2	Protein-Arginine DeiminasesIBA 02/2009 - 03/2008
2	TEMPOIBA 12/2007 - 03/2006
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2005 - 11/2000
2	Contrast MediaIBA 11/2002 - 09/2002
1	secukinumabIBA 01/2019
1	4-hexyloxyaniline (HOA)IBA 04/2016
1	golimumab FDA Link 10/2015
1	Inosine Monophosphate (IMP)IBA 09/2014
1	acetyl 4-aminosalicylic acidIBA 02/2010
1	VimentinIBA 02/2010
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2009
1	GlucocorticoidsIBA 04/2009
1	Prednisolone (Predate)FDA LinkGeneric 04/2009
1	HLA-DRB1 Chains (HLA DRB1)IBA 11/2008
1	AutoantibodiesIBA 11/2008
1	theasinensin AIBA 09/2008
1	Interleukin-6 (Interleukin 6)IBA 04/2008
1	Aligeron (AS 2)IBA 12/2006
1	EtoricoxibIBA 11/2005
1	Naproxen (Naprosyn)FDA LinkGeneric 11/2005
1	Leflunomide (Arava)FDA LinkGeneric 06/2004
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 09/2003
1	Pentetic Acid (DTPA)FDA LinkGeneric 09/2002

Therapy/Procedure

23	Therapeutics 01/2017 - 04/2001
3	Aftercare (After-Treatment) 04/2008 - 05/2004
2	Contraindications 03/2006 - 09/2003
2	Biological Therapy 03/2005 - 09/2003
1	Activities of Daily Living (ADL) 12/2018
1	Replacement Arthroplasty 12/2009
1	Perioperative Period 07/2009
1	Withholding Treatment 02/2006
1	Patient Care 03/2005
1	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2001
1	Physical Therapy Modalities (Physical Therapy Technique) 10/2001
1	Exercise Therapy (Therapy, Exercise) 10/2001